Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 7 | 2023 | 3075 | 0.840 |
Why?
|
| Pericarditis, Constrictive | 1 | 2021 | 42 | 0.830 |
Why?
|
| Pericardiectomy | 1 | 2021 | 45 | 0.820 |
Why?
|
| Hypertension, Renovascular | 1 | 2018 | 123 | 0.660 |
Why?
|
| Renin | 1 | 2018 | 618 | 0.580 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 382 | 0.490 |
Why?
|
| Oxidative Stress | 3 | 2021 | 3129 | 0.460 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2019 | 3475 | 0.400 |
Why?
|
| Kidney Transplantation | 2 | 2022 | 4140 | 0.380 |
Why?
|
| Mitochondria | 2 | 2022 | 3613 | 0.350 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2018 | 1156 | 0.340 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 1334 | 0.330 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3494 | 0.290 |
Why?
|
| Drug-Eluting Stents | 2 | 2022 | 719 | 0.260 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 1933 | 0.260 |
Why?
|
| Kidney | 1 | 2018 | 6882 | 0.230 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2022 | 59 | 0.210 |
Why?
|
| Coronary Artery Disease | 4 | 2022 | 6290 | 0.200 |
Why?
|
| Rats, Wistar | 3 | 2019 | 1977 | 0.190 |
Why?
|
| Antilymphocyte Serum | 1 | 2021 | 518 | 0.180 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2022 | 494 | 0.180 |
Why?
|
| Resistin | 1 | 2019 | 171 | 0.170 |
Why?
|
| Crocus | 1 | 2017 | 5 | 0.170 |
Why?
|
| Vascular Surgical Procedures | 2 | 2018 | 1459 | 0.160 |
Why?
|
| Cardioplegic Solutions | 1 | 2017 | 114 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 1986 | 0.160 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2017 | 82 | 0.160 |
Why?
|
| Orchiectomy | 1 | 2019 | 453 | 0.150 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1887 | 0.150 |
Why?
|
| Sarcoidosis | 1 | 2022 | 524 | 0.150 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 355 | 0.140 |
Why?
|
| Heart Arrest, Induced | 1 | 2017 | 366 | 0.140 |
Why?
|
| Protective Agents | 1 | 2017 | 162 | 0.140 |
Why?
|
| Acetylcysteine | 1 | 2017 | 275 | 0.140 |
Why?
|
| Carotid Body Tumor | 1 | 2015 | 32 | 0.140 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 303 | 0.130 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 480 | 0.130 |
Why?
|
| Myocardial Revascularization | 1 | 2018 | 847 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2017 | 457 | 0.120 |
Why?
|
| Hypogonadism | 1 | 2019 | 769 | 0.120 |
Why?
|
| Proteomics | 3 | 2022 | 3248 | 0.110 |
Why?
|
| Antioxidants | 2 | 2017 | 1670 | 0.110 |
Why?
|
| Heart Valve Prosthesis | 1 | 2021 | 1497 | 0.110 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 1345 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 1442 | 0.110 |
Why?
|
| Retinal Diseases | 1 | 2017 | 670 | 0.100 |
Why?
|
| Graft Rejection | 2 | 2022 | 4396 | 0.100 |
Why?
|
| Treatment Outcome | 11 | 2023 | 62040 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 1512 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2021 | 1486 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2021 | 1521 | 0.100 |
Why?
|
| Metabolome | 1 | 2017 | 871 | 0.100 |
Why?
|
| Cytokines | 3 | 2022 | 7189 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2017 | 1067 | 0.090 |
Why?
|
| Humans | 27 | 2023 | 715818 | 0.090 |
Why?
|
| Coronary Artery Bypass | 4 | 2022 | 2400 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 4379 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 2361 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2021 | 1844 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 1087 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2017 | 1243 | 0.090 |
Why?
|
| Proteome | 1 | 2018 | 1761 | 0.090 |
Why?
|
| Tissue Donors | 3 | 2023 | 2153 | 0.080 |
Why?
|
| Testosterone | 1 | 2019 | 2359 | 0.080 |
Why?
|
| Rats | 3 | 2022 | 24852 | 0.080 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 1022 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4193 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 2137 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3242 | 0.080 |
Why?
|
| Intestines | 1 | 2017 | 1924 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 2998 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2019 | 2754 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3884 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 1379 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5463 | 0.070 |
Why?
|
| Echocardiography | 1 | 2017 | 5045 | 0.070 |
Why?
|
| Rats, Zucker | 1 | 2022 | 138 | 0.060 |
Why?
|
| Male | 16 | 2022 | 350352 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3317 | 0.060 |
Why?
|
| Hypertension | 1 | 2022 | 8270 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2017 | 3159 | 0.060 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2022 | 36 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3149 | 0.050 |
Why?
|
| Interleukin-9 | 1 | 2022 | 67 | 0.050 |
Why?
|
| Adult | 9 | 2022 | 212279 | 0.050 |
Why?
|
| Infarction | 1 | 2022 | 224 | 0.050 |
Why?
|
| Endarterectomy | 1 | 2022 | 202 | 0.050 |
Why?
|
| Time Factors | 3 | 2018 | 40887 | 0.050 |
Why?
|
| Embolectomy | 1 | 2022 | 130 | 0.050 |
Why?
|
| Graft Survival | 2 | 2022 | 3753 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 4562 | 0.050 |
Why?
|
| Prevalence | 1 | 2017 | 14912 | 0.050 |
Why?
|
| Heart Failure | 1 | 2023 | 10041 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11090 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2022 | 526 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2022 | 909 | 0.040 |
Why?
|
| Animals | 6 | 2022 | 169404 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 2018 | 132 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15102 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 119 | 0.040 |
Why?
|
| Galectin 3 | 1 | 2019 | 217 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 1688 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2023 | 72473 | 0.040 |
Why?
|
| Galectins | 1 | 2019 | 250 | 0.040 |
Why?
|
| Aged | 8 | 2022 | 162468 | 0.040 |
Why?
|
| Female | 12 | 2022 | 377229 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11403 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2017 | 534 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1726 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 1928 | 0.030 |
Why?
|
| Blood | 1 | 2017 | 617 | 0.030 |
Why?
|
| Adipocytes | 1 | 2022 | 1173 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 697 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2022 | 15058 | 0.030 |
Why?
|
| Middle Aged | 8 | 2022 | 214666 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 567 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2021 | 2107 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2019 | 1128 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 70879 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 742 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2022 | 1743 | 0.030 |
Why?
|
| Child | 2 | 2017 | 74468 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2021 | 1446 | 0.030 |
Why?
|
| Reoperation | 1 | 2023 | 4177 | 0.030 |
Why?
|
| Length of Stay | 2 | 2017 | 6270 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2613 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2022 | 2158 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 22663 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2021 | 1837 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2015 | 661 | 0.020 |
Why?
|
| Algorithms | 2 | 2021 | 13758 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4454 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3947 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3225 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2018 | 893 | 0.020 |
Why?
|
| Leukocytes | 1 | 2017 | 2092 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1900 | 0.020 |
Why?
|
| Adiposity | 1 | 2018 | 1757 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2018 | 4905 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5984 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 58326 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29007 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9034 | 0.020 |
Why?
|
| Acute Disease | 1 | 2017 | 7142 | 0.020 |
Why?
|
| Registries | 1 | 2022 | 8048 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6552 | 0.020 |
Why?
|
| Retina | 1 | 2017 | 2631 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7901 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9849 | 0.020 |
Why?
|
| Heart | 1 | 2017 | 4315 | 0.020 |
Why?
|
| United States | 2 | 2022 | 67910 | 0.020 |
Why?
|
| Mice | 2 | 2022 | 80373 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2017 | 6258 | 0.010 |
Why?
|
| Patient Selection | 1 | 2015 | 4294 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10082 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13215 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15198 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18197 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 7565 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2015 | 4630 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39305 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 51317 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 56228 | 0.010 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_